Now showing items 1-10 of 10

    • Barta, John R.; Berghman, Luc; Shivaramaiah, Srichaitanya; Faulkner, Olivia B.; Bielke, Lisa; Hargis, Billy (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2017-03-28)
      Vaccine vectors and methods of using the vaccine vectors to enhance the immune response to an Apicomplexan parasite and reduce the morbidity or morality associated with subsequent infection are provided herein. The vaccine ...
    • Barta, John R.; Berghman, Luc; Shivaramaiah, Srichaitanya; Faulkner, Olivia B.; Bielke, Lisa; Hargis, Billy (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2018-02-06)
      Vaccine, vectors and methods of using the vaccine vectors to enhance the immune response to an Apicomplexan parasite and reduce the morbidity or mortality associated with subsequent infection are provided herein. The vaccine ...
    • Barta, John R.; Berghman, Luc; Shivaramaian, Srichaitanya; Faulkner, Olivia B.; Bielke, Lisa; Hargis, Billy, (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2019-06-25)
      Vaccine vectors and methods of using the vaccine vectors to enhance the immune response to an Apicomplexan parasite and reduce the morbidity or mortality associated with subsequent infection are provided herein. The vaccine ...
    • Barta, John R.; Berghman, Luc; Shivaramaiah, Srichaitanya; Faulkner, Olivia B.; Bielke, Lisa; Hargis, Billy (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2020-10-06)
      Vaccine vectors and methods of using the vaccine vectors to enhance the immune response to an Apicomplexan parasite and reduce the morbidity or mortality associated with subsequent infection are provided herein. The vaccine ...
    • Barta, John R.; Berghman, Luc; Shivaramaiah, Srichaitanya; Faulkner, Olivia B.; Bielke, Lisa; Hargis, Billy (United States. Patent and Trademark Office; Texas A&M University. Libraries, 6/21/2022)
      Vaccine vectors and methods of using the vaccine vectors to enhance the immune response to an Apicomplexan parasite and reduce the morbidity or mortality associated with subsequent infection are provided herein. The vaccine ...
    • Bielke, Lisa; Layton, Sherryll; Hargis, Billy; Pumford, Neil R.; Faulkner, Olivia B.; Berghman, Luc; Abi-Ghanem, Daad (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2019-08-13)
      Vaccine vectors capable of eliciting an immune response to enteric bacteria and methods of using the same are provided. The vaccine vectors include a polynucleotide encoding a PAL polypeptide. The PAL polypeptide may be ...
    • Bielke, Lisa; Layton, Sherryll; Pumford, Neil R.; Faulkner, Olivia B.; Berghman, Luc; Aby-Ghanem, Daad (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2020-07-21)
      Vaccine vectors capable of eliciting an immune response to enteric bacteria and methods of using the same are provided. The vaccine vectors include a polynucleotide encoding a PAL polypeptide. The PAL polypeptide may be ...
    • Bielke, Lisa; Layton, Sherryll; Hargis, Billy; Pumford, Neil R.; Faulkner, Olivia B.; Berghman, Luc; Abi-Ghanem, Daad (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2021-05-25)
      Vaccine vectors capable of eliciting an immune response to enteric bacteria and methods of using the same are provided. The vaccine vectors include a polynucleotide encoding a PAL polypeptide. The PAL polypeptide may be ...
    • Faulkner, Olivia B.; Bielke, Lisa; Calhoun, Leona Nicole; Berghman, Luc; Hargis, Billy (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2020-06-16)
      Vaccine compositions including a yeast comprising an immunostimulatory polypeptide and optionally an antigenic polypeptide are provided herein. The immunostimulatory polypeptide and the antigenic polypeptide are expressed ...
    • Faulkner, Olivia B.; Bielke, Lisa; Calhoun, Leona Nicole; Berghman, Luc; Hargis, Billy (United States. Patent and Trademark Office; Texas A&M University. Libraries, 7/12/2022)
      Vaccine compositions including a yeast comprising an immunostimulatory polypeptide and optionally an antigenic polypeptide are provided herein. The immunostimulatory polypeptide and the antigenic polypeptide are expressed ...